Cantor Fitzgerald Maintains Overweight on Quantinuum, Lowers Price Target to $55
Benzinga Newsdesk 8 hours ago
Analyst RatingsNewsPrice Target
Cantor Fitzgerald analyst Troy Jensen maintains Quantinuum (NASDAQ:QNT) with a Overweight and lowers the price target from $90 to $55.
Cantor Fitzgerald analyst Troy Jensen maintains Quantinuum (NASDAQ:QNT) with a Overweight and lowers the price target from $90 to $55.